Patents by Inventor Ka Wang

Ka Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD, APPARATUS, AND SYSTEM FOR DETERMINING AND MAINTAINING QUALITY OF SERVICE PARAMETERS ON A MULTI-HOP NETWORK
    Publication number: 20120127883
    Abstract: Disclosure of the present embodiments relate to a method, an apparatus, and a system for determining and maintaining quality of service parameters on a multi-hop network. The method for determining QoS parameters on a multi-hop network includes: in a data transmission process in a transmission path from a user equipment to an evolved NodeB, acquiring statistics of QoS parameters of a relay link in the transmission path; and determining, according to the statistics of the QoS parameters of the relay link and in combination with QoS parameters that need to be maintained in the transmission path and radio interface topology information in the transmission path, QoS parameters that need to be acquired by an access link and the relay link in the transmission path.
    Type: Application
    Filed: January 30, 2012
    Publication date: May 24, 2012
    Inventors: Ningjuan CHANG, Ka WANG, Yan PENG
  • Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
    Patent number: 7259166
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Grant
    Filed: April 10, 2006
    Date of Patent: August 21, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wendy Lea Corbett, Joseph Samuel Grimsby, Nancy-Ellen Haynes, Robert Francis Kester, Paige Erin Mahaney, Jagdish Kumar Racha, Ramakanth Sarabu, Ka Wang
  • Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
    Patent number: 7105671
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: September 12, 2006
    Assignee: Hoffmann-la Roche Inc.
    Inventors: Wendy Lea Corbett, Joseph Samuel Grimsby, Nancy-Ellen Haynes, Robert Francis Kester, Paige Erin Mahaney, Jagdish Kumar Racha, Ramakanth Sarabu, Ka Wang
  • Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
    Publication number: 20060178429
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 10, 2006
    Publication date: August 10, 2006
    Inventors: Wendy Corbett, Joseph Grimsby, Nancy-Ellen Haynes, Robert Kester, Paige Mahaney, Jagdish Racha, Ramakanth Sarabu, Ka Wang
  • Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
    Publication number: 20030225283
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 23, 2003
    Publication date: December 4, 2003
    Inventors: Wendy Lea Corbett, Joseph Samuel Grimsby, Nancy-Ellen Haynes, Robert Francis Kester, Paige Erin Mahaney, Jagdish Kumar Racha, Ramakanth Sarabu, Ka Wang